Skip to main content

Free Content Contra Pfizer

Download Article:
 Download
(PDF 170.5 kb)
 

Abstract:

Against a background of longstanding concerns that antidepressants may trigger suicidality, the Food and Drug Administration (FDA) in 2004 convened two committees to review the issues. Prior to the second meeting Pfizer posted an extensive ad hominem attack on me on FDA's website. There was no opportunity to post a response. This article covers the points made in response and sheds some light on pharmaceutical company handling of debates about adverse events.

Keywords: FDA; SERTRALINE; SUICIDE; WARNINGS

Document Type: Research Article

Publication date: September 1, 2005

More about this publication?
springer/ehpp/2005/00000007/00000003/art00002
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more